Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Sell
34
HSY Quote, Financials, Valuation and Earnings
Last price:
$167.14
Seasonality move
:
3.2%
Day range:
$164.26 - $167.86
52-week range:
$140.13 - $211.92
Dividend yield:
3.28%
P/E ratio:
15.34x
P/S ratio:
3.65x
P/B ratio:
7.18x
Volume:
3M
Avg. volume:
2.1M
1-year change:
-16.12%
Market cap:
$33.8B
Revenue:
$11.2B
EPS (TTM):
$10.90
Analysts' Opinion
-
Consensus RatingThe Hershey has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 17 Hold ratings, and 3 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $162.34, The Hershey has an estimated downside of -2.89% from its current price of $167.18.
-
Price Target UpsideAccording to analysts, the highest upside price target is $211.56 representing -100% upside increase from its current price of $167.18.
Fair Value
-
According to the consensus of 22 analysts, The Hershey has -2.89% downside to fair value with a price target of $162.34 per share.
HSY vs. S&P 500
-
Over the past 5 trading days, The Hershey has underperformed the S&P 500 by -2.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
The Hershey does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Hershey has grown year-over-year revenues for 1 quarter straight. In the most recent quarter The Hershey reported revenues of $2.9B.
Earnings Growth
-
The Hershey has grown year-over-year earnings for 1 quarter straight. In the most recent quarter The Hershey reported earnings per share of $3.92.
Enterprise value:
38.1B
EV / Invested capital:
--
Price / LTM sales:
3.65x
EV / EBIT:
14.40x
EV / Revenue:
3.40x
PEG ratio (5yr expected):
0.75x
EV / Free cash flow:
19.80x
Price / Operating cash flow:
21.22x
Enterprise value / EBITDA:
12.29x
Gross Profit (TTM):
$5.3B
Return On Assets:
17.83%
Net Income Margin (TTM):
19.83%
Return On Equity:
52.54%
Return On Invested Capital:
23.63%
Operating Margin:
32.4%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $10.4B | $11.2B | $11.2B | $2.7B | $2.9B | |
| Gross Profit | $4.5B | $5B | $5.3B | $1.1B | $1.6B | |
| Operating Income | $2.3B | $2.6B | $2.9B | $464.3M | $935.6M | |
| EBITDA | $2.4B | $2.8B | $3.1B | $476.5M | $888.7M | |
| Diluted EPS | $7.96 | $9.05 | $10.90 | $1.70 | $3.92 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3B | $2.2B | $2.6B | $2.9B | $3.8B | |
| Total Assets | $9.1B | $10.4B | $10.9B | $11.9B | $12.9B | |
| Current Liabilities | $1.9B | $2.5B | $3.3B | $3B | $3.9B | |
| Total Liabilities | $6.9B | $7.7B | $7.6B | $7.8B | $8.2B | |
| Total Equity | $2.2B | $2.8B | $3.3B | $4.1B | $4.7B | |
| Total Debt | $4.5B | $5B | $4.8B | $4.7B | $5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.3B | $2.3B | $2.5B | $757.6M | $941.6M | |
| Cash From Investing | -$787.4M | -$1.2B | -$960.3M | -$463.1M | -$411M | |
| Cash From Financing | -$1.4B | -$1.1B | -$1.3B | -$363.9M | -$449.5M | |
| Free Cash Flow | $1.8B | $1.6B | $1.9B | $535.1M | $807.1M | |
HSY
Sector
Market Cap
$33.8B
$282.5M
Price % of 52-Week High
78.89%
72.58%
Dividend Yield
3.28%
0%
Shareholder Yield
4.57%
3.03%
1-Year Price Total Return
-16.12%
-12.27%
Beta (5-Year)
0.323
0.460
Dividend yield:
3.28%
Annualized payout:
$5.48
Payout ratio:
48.84%
Growth streak:
15 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$169.00
200-day SMA
Sell
Level
$180.77
Bollinger Bands (100)
Sell
Level
158.3 - 180.22
Chaikin Money Flow
Buy
Level
284.2M
20-day SMA
Sell
Level
$173.12
Relative Strength Index (RSI14)
Sell
Level
46.44
ADX Line
Buy
Level
26.32
Williams %R
Buy
Level
-88.5687
50-day SMA
Buy
Level
$162.16
MACD (12, 26)
Buy
Level
1.18
25-day Aroon Oscillator
Buy
Level
56
On Balance Volume
Neutral
Level
132.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.6387)
Buy
CA Score
(Annual)
Level (0.1826)
Buy
Beneish M-Score
(Annual)
Level (-2.6648)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.6188)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Hershey is a leading US confectionery manufacturer (around a $54 billion market, according to Euromonitor), controlling around 36% of the domestic chocolate space. Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the US, including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix, Pirate Brands, and Dot's Pretzels over the past few years.
Stock Forecast FAQ
In the current month, HSY has received 2 Buy ratings 17 Hold ratings, and 3 Sell ratings. The HSY average analyst price target in the past 3 months is $162.34.
-
Where Will The Hershey Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Hershey share price will drop to $162.34 per share over the next 12 months.
-
What Do Analysts Say About The Hershey?
Analysts are divided on their view about The Hershey share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that The Hershey is a Buy and believe this share price will rise from its current level to $211.56.
-
What Is The Hershey's Price Target?
The price target for The Hershey over the next 1-year time period is forecast to be $162.34 according to 22 Wall Street analysts, 2 of them rate the stock a Buy, 3 rate the stock a Sell, and 17 analysts rate the stock a Hold.
-
Is HSY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Hershey is a Hold. 17 of 22 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of HSY?
You can purchase shares of The Hershey via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Hershey shares.
-
What Is The The Hershey Share Price Today?
The Hershey was last trading at $167.14 per share. This represents the most recent stock quote for The Hershey. Yesterday, The Hershey closed at $167.18 per share.
-
How To Buy The Hershey Stock Online?
In order to purchase The Hershey stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
